|
11. |
Complementary and alternative medicine for pain management in rheumatic disease |
|
Current Opinion in Rheumatology,
Volume 14,
Issue 1,
2002,
Page 58-62
E. Ernst,
Preview
|
PDF (73KB)
|
|
摘要:
Complementary and alternative medicine has become immensely popular. This review summarizes the recent literature on complementary and alternative medicine for rheumatic conditions. Research has emerged in the following areas: acupuncture, herbal remedies, homeopathy, magnetic fields, massage therapy, spiritual healing, and supplements. Positive evidence was found in relation to glucosamine, chondroitin, some herbal remedies, and acupuncture. Generally speaking, complementary and alternative medicine is grossly underresearched. Because of the popularity of complementary and alternative medicine, adequately defining risk-benefit relationships is an urgent matter.
ISSN:1040-8711
出版商:OVID
年代:2002
数据来源: OVID
|
12. |
Use of nonopioid analgesics and adjunctive agents in the management of pain in rheumatic diseases |
|
Current Opinion in Rheumatology,
Volume 14,
Issue 1,
2002,
Page 63-71
Warren Katz,
Preview
|
PDF (97KB)
|
|
摘要:
Antirheumatic analgesic medications generally fall into one of the following categories: acetaminophen, corticosteroids, nonsteroidal anti-inflammatory drugs (NSAIDs), tramadol, traditional opioids, or adjunctive analgesics. This article does not discuss corticosteroids, opioids, or topical analgesics. Acetaminophen, usually indicated early for mild pain, is often used in combination with other drugs. It has established safety. Traditional NSAIDs are effective in relieving moderate pain in certain inflammatory and noninflammatory conditions. There are many effective choices, but as a class it is fraught with the risk of serious peptic ulcer disease and its complications. Cyclooxygenase-2 specific inhibitors are NSAIDS that reduce the gastrointestinal risk and platelet-mediated bleeding. All NSAIDs may produce peripheral edema, hypertension, and potentiate warfarin. The evidence that coxibs cause thrombotic heart disease is weak. Tramadol is an alternative to musculoskeletal pain management, particularly in patients with moderate to moderately severe pain who do not respond to or who cannot tolerate acetaminophen, NSAIDs, or opioids. The role of analgesic adjuvants is discussed.
ISSN:1040-8711
出版商:OVID
年代:2002
数据来源: OVID
|
13. |
BibliographyCurrent World Literature |
|
Current Opinion in Rheumatology,
Volume 14,
Issue 1,
2002,
Page 73-85
Preview
|
|
ISSN:1040-8711
出版商:OVID
年代:2002
数据来源: OVID
|
|